Regorafenib (Stivarga) plus nivolumab (Opdivo) displayed noninferior survival and a numerically higher response rate and disease control rate (DCR) compared with chemotherapy for patients with previously treated, refractory, advanced gastric or…
Category: 6. Business
-

New Biomarkers, Drug Targets Identified for Colorectal Cancer
Using bioinformatics, researchers identified region-specific biomarkers—FGFR4, FLT1, and WNT5A—that drive distinct tumor behaviors and may serve as diagnostic and therapeutic targets.1 Additionally, the researchers identified 2 promising…
Continue Reading
-
Introductory Remarks at the IMF’s Western Hemisphere Department Press Briefing – International Monetary Fund
- Introductory Remarks at the IMF’s Western Hemisphere Department Press Briefing International Monetary Fund
- Latin America, Caribbean economies to remain steady this year before slight slowdown Miami Herald
- Brazil, Mexico Drive Upward Revision of…
Continue Reading
-

Adjuvant Ribociclib Plus AI Therapy Has Long-Term Activity in HR+, HER2-Negative Early Breast Cancer
Adjuvant ribociclib (Kisqali) in combination with a nonsteroidal aromatase inhibitor (AI) displayed a durable benefit in terms of invasive disease–free survival (iDFS) compared with an AI alone (n = 2552) in patients with hormone…
Continue Reading
-

Abemaciclib Plus Endocrine Therapy Provides OS Benefit in HR+/HER2-Negative Breast Cancer
Adjuvant abemaciclib (Verzenio) plus endocrine therapy significantly reduced the risk of death by 15.8% compared with endocrine therapy alone in patients with hormone receptor–positive, HER2-negative, high-risk early breast cancer (HR, 0.842; 95%…
Continue Reading
-

Orrick Continues to Expand Asia Energy Platform with Tokyo Hire
- Akira Takahashi joins Orrick from RWE Renewables as a partner on our Energy & Infrastructure team in Tokyo.
- Akira, who is Japanese and New York law-qualified, brings deep experience advising on international energy projects and…
Continue Reading
-

Hilton Expands Resorts Portfolio with New Signing in Croatia Under Flagship Brand
Hilton Lopud Beach Resort & Spa marks the third Hilton Hotels & Resorts property in Croatia, and Hilton’s first property on Lopud Island.
LOPUD ISLAND, Croatia – 17 October 2025 – Hilton (NYSE: HLT) today announced the signing of Hilton…
Continue Reading
-
Chair’s Statement Fifty-Second Meeting of the IMFC – Mr. Mohammed Aljadaan, Minister for Finance of Saudi Arabia – International Monetary Fund
- Chair’s Statement Fifty-Second Meeting of the IMFC – Mr. Mohammed Aljadaan, Minister for Finance of Saudi Arabia International Monetary Fund
- IMF’s Georgieva says countries lack regulatory, ethical foundation for AI Reuters
- IMF Steering…
Continue Reading
-

Lenvatinib Plus Pembrolizumab and Chemotherapy Fails to Improve OS in Advanced ESCC
The combination of lenvatinib (Lenvima) and pembrolizumab (Keytruda) plus chemotherapy failed to improve overall survival (OS) vs pembrolizumab plus chemotherapy alone as frontline treatment in patients with metastatic esophageal squamous cell…
Continue Reading

